| Application no. and date | 10193919.7 (espacenet) (Federated) (European Patent Register), 20050322 | | Patent/reg. no. and date | DK/EP 2314632, 20130123 | | Publication date | 20110427 | | Priority no. and date | EP 04290791, 20040324 | | EP pub. no. and date |
EP 2314632 20110427 | | Effective date | | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92160 Antony, FR | | Applicant ref. no. | AVENTIS FRAV2004/0007 | | Inventor | Mourier, Pierre,
c/o Sanofi-Aventis Département Brevets 174 Avenue
75013, PARIS, FR,
Viskov, Christian,
c/o Sanofi-Aventis Département Brevets 174 Avenue
75013, PARIS, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | C07H 3/06 (2006.01) , C08B 37/00 (2006.01) , C12Q 1/527 (2006.01) | | Title | Oligosaccharidforbindelser, der er afledt af heparin | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
